AtriCure, Inc. (ATRC) by event type
ATRC moves most on price-target cuts — a median of -2.25% at 30 minutes across 16 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the ATRC overview →
How ATRC reacts across 5 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 1,925 of 2,717 | 14 | -0.17% | 43% | -2.00% |
| Analyst downgrades 2,462 of 2,603 | 15 | -1.29% | 33% | -0.25% |
| Rating reiterations 3,326 of 3,522 | 76 | -0.53% | 38% | -1.24% |
| Price-target raises 1,626 of 1,790 | 17 | -0.25% | 29% | -0.80% |
| Price-target cuts 1,526 of 1,527 | 16 | -2.25% | 19% | -1.77% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.
That’s how ATRC usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Rating reiterations → · Price-target raises → · Price-target cuts → · ATRC overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CORREVIO PHARMA CORP ORDINARY SHARES (CORV) | 279 | 0.00% | 44% |
| Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares (CANF) | 278 | -0.48% | 36% |
| Coherus Oncology, Inc. (CHRS) | 276 | +0.21% | 51% |
| Xenon Pharmaceuticals Inc. - Common Shares (XENE) | 276 | +0.03% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.